Cart
sales@molnova.com
WAY-383487
CAS No. 748146-89-6
WAY-383487( —— )
Catalog No. M28817 CAS No. 748146-89-6
WAY-383487 is one of the Tat peptide derivatives and inhibits HIV-1 long terminal repeat-activated transcription.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 110 | In Stock |
|
| 5MG | 116 | In Stock |
|
| 10MG | 187 | In Stock |
|
| 25MG | 316 | In Stock |
|
| 50MG | 462 | In Stock |
|
| 100MG | 644 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 1349 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameWAY-383487
-
NoteResearch use only, not for human use.
-
Brief DescriptionWAY-383487 is one of the Tat peptide derivatives and inhibits HIV-1 long terminal repeat-activated transcription.
-
DescriptionWAY-383487 is one of the Tat peptide derivatives and inhibits HIV-1 long terminal repeat-activated transcription.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMicrobiology/Virology
-
TargetHIV
-
RecptorMicrotubule Associated
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number748146-89-6
-
Formula Weight293.338
-
Molecular FormulaC16H20FNO3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESOC(=O)CC1(CC(=O)Nc2ccc(F)cc2)CCCCC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Kwon A, et al. Potent Small-Molecule Inhibitors Targeting Acetylated Microtubules as Anticancer Agents Against Triple-Negative Breast Cancer. Biomedicines. 2020 Sep 9;8(9):338.
molnova catalog
related products
-
Tenofovir Disoproxil...
Tenofovir Disoproxil Fumarate is a nucleotide reverse transcriptase inhibitor to treat HIV and chronic Hepatitis B.
-
TAK-779
TAK-779 is a potent, specific, nonpeptide CCR5 antagonist with Kd of 0.45 nM.
-
Doravirine
Doravirine (MK-1439, MK1439) is a novel, highly specific HIV-1 nonnucleoside reverse transcriptase inhibitor (NNRTI) with IC50 of 12, 9.7, and 9.7 nM against WT, K103N, and Y181C reverse transcriptase (RT) mutants, respectively.
